Panel Discussion: What Have We Learned From the Past 30 Years on the Pathophysiology of Cardiogenic Shock

Saturday, February 25, 2023

9:04 AM – 9:20 AM ET

Panel Moderator(s)

Daniel Burkhoff, MD, PhD

Director: Heart Failure, Hemodynamics and MCS Research
Cardiovascular Research Foundation
New York, New York, United States

Disclosure information not submitted.
Navin K. Kapur, MD, FSCAI FAHA FACC

Executive Director, CVCRI
Tufts Medical Center
Boston, Massachusetts, United States

Disclosure information not submitted.
James A. Goldstein, MD, FSCAI

Director, Research and Education
Beaumont Health System
Royal Oak, Michigan, United States

Disclosure information not submitted.

Panel Discussant(s)

Abdulla A. Damluji, MD, PhD, MPH

Interventional Cardiologist
Inova Heart and Vascular Institute
Falls Church, Virginia, United States

No relationships to disclose
Tariq Enezate, MD

Interventional Cardiology Faculty
OSF-Urbana
Urbana, Illinois, United States

No relationships to disclose
Maya Guglin, MD

Director of Heart Failure/Transplant/MCS
Indiana University
Indianapolis, Indiana, United States

No relationships to disclose
Amir Kaki, MD, FACC, FSCAI

Director Mechanical Circulatory Support Director High-Risk Complex Coronary Interventions
Ascension St John Hospital
Southfield, Michigan, United States

Disclosure(s): Abbott Vascular, Edwards, Medtronic, Boston Scientific: Consultant (Ongoing); Abiomed: Consultant (Ongoing); CSI: Consultant (Ongoing)
ramesh Mazhari, MD

Professor of Medicine, Director of Cardiovascular ICU
George Washington University, District of Columbia, United States

No relationships to disclose
Susan O'Donoghue, MD

Electrophysiologist Director, Cardiogenetics Services
MedStar Washington Hospital Center, MedStar Heart and Vascular Institute
Washington, District of Columbia, United States

No relationships to disclose
Mohit Pahuja, MD

Assistant Professor of Medicine, Division of Interventional and advanced heart failure cardiology
University of Oklahoma Medical Center
OKC, Oklahoma, United States

No relationships to disclose
Mohammad Sarraf, MD

Interventional Cardiology
Mayo Clinic
Rochester, Minnesota, United States

No relationships to disclose
Shashank S. Sinha, MD, MSc

Director, Cardiac ICU; Director, Cardiovascular Critical Care Research
Inova Heart and Vascular Institute, Virginia, United States

No relationships to disclose
Saraschandra Vallabhajosyula, MD MSc

Assistant Professor of Medicine and Implementation Science
Wake Forest University School of Medicine
High Point, North Carolina, United States

No relationships to disclose

Disclosure(s):

Daniel Burkhoff, MD, PhD: Impulse Dynamics: Consultant (Ongoing)

James A. Goldstein, MD, FSCAI: ECLS, Inc which licenses radiation shiled technology to Image Diagnostics, Inc: Intellectual Property/Patents (Ongoing), Major Stockholder (not including mutual funds) (Ongoing), Officer or Board Member (Ongoing), Royalties (Ongoing)

Amir Kaki, MD, FACC, FSCAI: Abbott Vascular, Edwards, Medtronic, Boston Scientific: Consultant (Ongoing); Abiomed: Consultant (Ongoing); CSI: Consultant (Ongoing)